Mandate

Vinge advises Jays Group on a rights issue

The board of directors of Jays Group AB (publ) has resolved pursuant to authorization granted at an annual general meeting to perform a new issue of shares amounting to approximately MSEK 41 subject to pre-emption rights for the company’s existing shareholders.

Pursuant to subscription undertakings and guarantee obligations, the new issue of shares is secured to approximately MSEK 36.9, corresponding to 90% of the total proceeds of the new issue of shares. The offer is performed in order to further strengthen the company’s trademark and product portfolio and strengthen the balance sheet prior to future acquisition financing. The prospectus is planned to be published on 24 May and the subscription period commences on 27 May.

Vinge’s team consists of responsible partner Anders Strid together with Frida Bergqvist (project manager), Jenny Sandlund, Victor Ericsson (tax) and Camilla Andersson (company assistant).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025